Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Transgene S.A.
Capsule is 70% smaller than tablets of omeprazole currently available in Prilosec OTC and generic equivalents, including formulations Perrigo provides for its private label and store brand customers.
The start-up is built around four business units – technology, manufacturing, R&D and therapeutics – based on internal and external expertise. Kriya will take its first gene therapies into the clinic in 2023.
Perrigo is set to welcome a new chief financial officer and corporate security head as it rounds up a fairly successful first quarter.
“We said we would start growing this company ... and this is the year to do it,” says CERO Murray Kessler. With nearly 11% net sales growth for its Americas business leading nearly 10% overall Q1 growth, Perrigo raises full-year guidance for net sales growth to 8% to 9%, up earlier 7% to 8%.
- Gene Therapy, Cell Therapy